www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

PF-9363

Catalogue number:
CAY37778-25 mg
Supplier:
Size:
25 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£971.00 Estimated delivery Wed 15 Apr
Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

2569009-58-9

Purity:

≥98%

Formulation:

A solid

Molecular Formula:

C20H20N4O6S

Molecular Weight:

444.5

Alternative Names:

2,6-dimethoxy-n-[4-methoxy-6-(1h-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]-benzenesulfonamide, ctx-648

Product Description:

A KAT6A and KAT6B inhibitor (Kis = 0.27 and 2.4 nM, respectively); selective for KAT6A and KAT6B over KAT7, KAT5, and KAT8 (Kis = 70, 420, and 670 nM, respectively); reduces the proliferation of, and the levels of H3K23Ac and H3K14Ac in, ZR-75-1 cancer cells (IC50s = 0.37, 0.85, and 120 nM, respectively); reduces tumor levels of H3K23Ac and tumor volume without affecting body weight in a ZR-75-1 breast cancer mouse xenograft model at 0.03, 03, or 5 mg/kg per day; reduces tumor volume and increases survival in a PDX mouse model of breast cancer at 1 mg/kg per day